The Fort Worth Press

Three charged with sneaking Nvidia AI chips from US into China

Employees of a US computer company raked in billions of dollars diverting Nvidia artificial intelligence chips to China in violation of export controls, according to an indictment unsealed Thursday.

Avel eCare Calls for Virtual Health Integration in State Rural Health Transformation Strategies

SIOUX FALLS, SD / ACCESS Newswire / March 20, 2026 / States across the country are preparing to deploy $50 billion in federal funding through the Rural Health Transformation Program (RHT) to modernize care delivery, stabilize rural hospitals, and strengthen healthcare access for rural communities.

TRNR Authorizes First Stock Repurchase Program; $500,000 Program Represents 20% Of Shares Outstanding at Last Closing Price

Guidance of more than $30 million in pro forma 2026 revenue and near-term profitability highlights TRNR share price opportunityProfit of more than $500,000 after expenses on Sportstech Loan repayment drives TRNR's initial Stock Repurchase Program

Organto Foods Inc. Announces Marketing Engagements with VSA Capital Limited and Venture Liquidity Partner Ltd.

VANCOUVER, BC AND BREDA, THE NETHERLANDS / ACCESS Newswire / March 20, 2026 / Organto Foods Incorporated (TSXV:OGO)(OTCQX:OGOFF)(FSE:OGF0) ("Organto" or the "Company") is pleased to announce that it has engaged both VSA Capital Limited ("VSA Capital"), a London, U.K.-based investment banking firm, to provide marketing and communications support services, and Venture Liquidity Providers Inc. ("VLP"), a Canadian-based market-making services firm for market-making purposes.

California to rename Cesar Chavez Day after sex abuse claims

Lawmakers in California said Thursday they will rename the Cesar Chavez Day state holiday in the wake of disturbing allegations of sexual abuse by the late labor rights icon.

Yazidi woman tells French court of rape, slavery and escape from IS

A Yazidi woman who was held as a sex slave by the Islamic State group testified Thursday before a French court, describing in stark detail the horrors she endured under jihadist captivity.

Wimbledon expansion plan gets legal boost

Wimbledon's controversial expansion plan received a major boost Thursday after a judge at London's High Court ruled the proposed development of the current site is not subject to restrictions on how the land cam be used.

Social media addiction trial jury deliberations continue

Jurors will return to court here on Thursday to continue deliberations in a civil trial accusing Meta and YouTube of harmfully hooking young internet users.

Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference

SAN DIEGO, CA / ACCESS Newswire / March 19, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation to optimize health, announced today that James Rolke, Revelation's Chief Executive Officer, and Chester S. Zygmont, III, Revelation's Chief Financial Officer, will be attending the 38th Annual Roth Conference, in Dana Point, CA, on Monday and Tuesday March 23rd and 24th. On Tuesday, March 24, 2026, at 2:00 p.m. PT, the Company will participate in a fireside chat.

Wellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per Share

TAMPA, FL / ACCESS Newswire / March 19, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today announced that its President and Interim Chief Executive Officer, Prashant Patel, together with an additional participant from the Company's Board of Directors, entered into agreements with the Company to convert an aggregate of approximately $2.0 million of accrued compensation into shares of the Company's common stock at a conversion price of $0.20 per share, representing a premium to the Company's recent trading price. In connection with the conversion, the Company will issue approximately 10,000,000 shares of common stock.

Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion

Agreement Set to Expand BUZZ BOMB™ Distribution Across Natural, Specialty, and Mass Merchandiser Channels

New to The Street Renews 12-Part Media Series with Roadzen, Inc. (NASDAQ: RDZN)

Integrated Campaign to Include National Broadcast Interviews, Times Square Billboards, Earned Media, NewsOut PR Distribution, and Non-Deal Roadshow Events

Colombia detains alleged mastermind of Ecuadoran candidate assassination

Colombian immigration authorities said Wednesday they had arrested an Ecuadoran drug trafficker linked to the 2023 murder of a popular candidate just before Ecuador's presidential election.

NY's New Museum returns contemporary to heart of Manhattan

After an $82 million expansion, New York's New Museum will bring contemporary art back to the heart of Manhattan, showcasing modern works alongside classics by Dali and Marcel Duchamp after two years closed.

Trump nominee for Homeland Security chief grilled at fiery Senate hearing

Markwayne Mullin, US President Donald Trump's pick for Homeland Security chief, distanced himself from his fired predecessor Kristi Noem as he was grilled over immigration policy at a contentious Senate confirmation hearing on Wednesday.

Eight killed during Rio police operation, including drug kingpin

At least eight people died Wednesday during a police operation against organized crime in Rio de Janeiro, including one of Brazil's most-wanted drug lords, authorities said.

Colombia detains suspect in 2023 killing of Ecuador politician

Colombian immigration authorities said Wednesday that they had arrested an Ecuadoran drug trafficker linked to the 2023 murder of a popular candidate just before Ecuador's presidential election.

US launches new era of drug war with Latin American allies

The United States and allies in Latin America and the Caribbean have ushered in a new phase of anti-drug cooperation including extraditions, shared intelligence and security plans despite criticism from international organizations.

Foreign press group slams Israeli police for breaking journalist's wrist

An international media association on Wednesday criticised an "unprovoked assault" by Israeli police on journalists in Jerusalem, which it said left a CNN producer with a fractured wrist.

EU lawmakers back ban on sexualised AI deepfakes

EU lawmakers on Wednesday approved a ban on AI systems generating sexualised deepfakes, after a global outcry over non-consensual nudes created by Elon Musk's chatbot Grok.

Seven-year term sought for Norway princess's son for alleged rapes

Prosecutors in Norway called Wednesday for the son of Crown Princess Mette-Marit, Marius Borg Hoiby, to serve seven years and seven months in prison for offences including the alleged rape of four women.

Chinese tourists ditch Japan for third month running

Chinese visitors to Japan tumbled 45.2 percent in February from a year earlier, official data showed Wednesday, as the fallout from the countries' diplomatic spat bit for the third month running.

Chinese visitors to Japan plunge 45.2% in February

Chinese visitors to Japan tumbled 45.2 percent in February from a year earlier, official data showed Wednesday, as the fallout from the countries' diplomatic spat bit for the third month running.

Trespasser caught in viral hippo Moo Deng's Thai zoo pen

A Thai man broke into the zoo enclosure of Moo Deng, an endangered baby pygmy hippo and internet sensation, police said Wednesday, as the zoo filed a trespassing complaint.

ZeOmega Recognized in the 2026 Gartner(R) Market Guide for Intelligent Prior Authorization, U.S. Healthcare Organizations

PLANO, TX / ACCESS Newswire / March 18, 2026 / ZeOmega, the industry's leading population health management organization, today announced it was listed in Gartner's 2026 Market Guide for Intelligent Prior Authorization. The report names ZeOmega as a Representative Vendor in the intelligent prior authorization (iPA) market and mentions the company's Smart Auth Optimizer solution's capabilities designed to streamline prior authorization workflows using AI and automation.

FDA Feedback Supports Extension Phase for Jaguar Health's Clinical Trial of Crofelemer for Treatment of Microvillus Inclusion Disease (MVID)

MVID has a lethal natural history requiring life-sustaining parenteral support (PS), which includes total parenteral nutrition (TPN), which is associated with significant toxicities; PS reduction could potentially reduce co-morbidities and improve clinical benefit, as no approved therapies exist for MVIDJaguar launches news alert text service for investors - click here to sign up for text alerts

Mercury CEO Josh Medow Named "Rising Star" in 2026 Pros to Know Awards by Supply & Demand Chain Executive

The 2026 Pros to Know Awards recognizes outstanding executives who serve as an example for other leaders looking to leverage supply chain for competitive advantage.

Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin

BOULDER, CO / ACCESS Newswire / March 18, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, and animal health care, today announced the launch of Aquanil® AD, a hypochlorous acid based dermatology product line for sensitive skin, developed exclusively for Persōn & Covey, Inc. for distribution through its established over-the-counter dermatology channels in the United States.

#paid and Pinterest Announce Strategic Partnership to Power Creator-Led Commerce at the Moment of Decision

New Partnership Connects Brands With Consumers at the Point of Decision Through Creator-Led Media

Protagonist Therapeutics Announces U.S. FDA Approval of ICOTYDE(TM) (icotrokinra) for the Treatment of Moderate to Severe Plaque Psoriasis

ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pillApproval supported by four phase 3 studies that met all primary endpoints and demonstrated a favorable safety profile in 2,500 patients$50 million milestone payment triggered by FDA approval; Protagonist is eligible to receive 6 - 10% royalties on sales and up to $580 million in future milestone paymentsWebcast and conference call to be held at 8:30 am ET on March 18

Medicus Pharma To Discuss Positive Skinject(R) Phase 2 Topline Results In Fireside Chat Hosted By Brookline Capital Markets Biotechnology Equity Research Analyst

Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid immediate surgical intervention.

US judge orders Trump admin to bring VOA employees back to work

A US federal judge on Tuesday ordered the Trump administration to bring more than 1,000 Voice of America employees back to work and resume broadcasts by the government-funded media outlet.

The Fort Worth Press - Boulevard (English)

Featured

Residents recount guilt, chaos in hearing on deadly Hong Kong fire

IPL's Bengaluru to keep 11 seats empty in honour of stampede dead

Last news